BSPK (Bespoke Extracts) 3-Year RORE % : -36.59% (As of Sep. 2025)


BSPK Bespoke Extracts Inc BSPK
10 GF Score
Price $0.12
GF Value $0.21
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Bespoke Extracts 3-Year RORE %?

Bespoke Extracts BSPK 10 3-Year RORE % is -36.59 as of Sep. 2025. GuruFocus rates BSPK with a GF Score™ of 10/100 and a GF Value™ of $0.21 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 936 Drug Manufacturers companies, Bespoke Extracts ranks worse than 76.39% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Bespoke Extracts's 3-Year RORE % for the quarter that ended in Sep. 2025 was -36.59%.

The industry rank for Bespoke Extracts's 3-Year RORE % or its related term are showing as below:

BSPK's 3-Year RORE % is ranked worse than
76.39% of 936 companies
in the Drug Manufacturers industry
Industry Median: 3.075 vs BSPK: -36.59

Bespoke Extracts  (OTCPK:BSPK) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Bespoke Extracts 3-Year RORE % Related Terms


Bespoke Extracts 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Bespoke Extracts's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bespoke Extracts 3-Year RORE % Chart

Bespoke Extracts Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23 Dec24
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -82.15 -1,162.44 0.00 0.00 -51.70

Bespoke Extracts Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.75 -51.70 -47.37 -44.03 -36.59

BSPK vs IMCC, NPHC, SKYI: 3-Year RORE % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bespoke Extracts 3-Year RORE % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Bespoke Extracts's 3-Year RORE % falls into.


BSPK
10GF Score
Bespoke Extracts Inc BSPK
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bespoke Extracts 3-Year RORE % Calculation

Bespoke Extracts's 3-Year RORE % for the quarter that ended in Sep. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.07--0.22 )/( -0.41-0 )
=0.15/-0.41
=-36.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -36.59 mean?
Bespoke Extracts (BSPK) has a 3-Year RORE % of -36.59 as of Sep. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Bespoke Extracts and its competitors. According to the industry distribution chart, Bespoke Extracts ranks #715 out of 936 companies in the Drug Manufacturers industry, placing it in the top 76.4%.
Is Bespoke Extracts' 3-Year RORE % too high?
Bespoke Extracts' current 3-Year RORE % is -36.59. Based on the distribution chart, Bespoke Extracts ranks #715 out of 936 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Bespoke Extracts has a GF Score™ of 10/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bespoke Extracts' 3-Year RORE % compare to IMCC and NPHC?
According to the Drug Manufacturers industry distribution chart, Bespoke Extracts ranks #715 out of 936 companies for 3-Year RORE %. This places Bespoke Extracts in the lower half of its industry. The industry median 3-Year RORE % is 3.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Drug Manufacturers company?
The median 3-Year RORE % among Drug Manufacturers companies is 3.08, based on 936 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Bespoke Extracts and its competitors. For the Drug Manufacturers industry, the median 3-Year RORE % is 3.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bespoke Extracts's current 3-Year RORE % is -36.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bespoke Extracts stock overvalued right now?
Based on GuruFocus' analysis, Bespoke Extracts (BSPK) is currently considered Possible Value Trap. The stock's GF Value™ is $0.21, compared to a current price of $0.12 — trading 42.7% below its estimated fair value. The current 3-Year RORE % is -36.59. Bespoke Extracts' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Bespoke Extracts (BSPK), the current 3-Year RORE % is -36.59 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bespoke Extracts (BSPK) Overvalued in 2026?

Based on GuruFocus' analysis, Bespoke Extracts stock appears to be undervalued. The current stock price of $0.12 is trading 42.7% below its estimated GF Value™ of $0.21. GuruFocus considers Bespoke Extracts to be Possible Value Trap.

Key valuation signals for BSPK:

  • 3-Year RORE %: -36.59
  • GF Value™: $0.21 vs. price of $0.12 (42.7% below fair value)
  • GF Score™: 10/100 with 4 warning signs

No single metric tells the full story. See the BSPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bespoke Extracts Business Description

Address 12001 East 33rd Avenue, Unit O, Aurora, Denver, CO, USA, 80010
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, quality, hemp-derived CBD products. The company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Doobskis, DutchBlunts, and Wee Joints, to licensed marijuana dispensaries across Colorado.
10GF Score

Get the complete analysis for BSPK

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price
$0.21
GF Value